No relevant modulation of TRPV1-mediated trigeminal pain by intranasal carbon dioxide in healthy humans
- PMID: 23574808
- PMCID: PMC3630066
- DOI: 10.1186/1129-2377-14-33
No relevant modulation of TRPV1-mediated trigeminal pain by intranasal carbon dioxide in healthy humans
Abstract
Background: Nasal insufflation of CO2 has been shown to exert antinociceptive respectively antihyperalgesic effects in animal pain models using topical capsaicin with activation of TRPV1-receptor positive nociceptive neurons. Clinical benefit from CO2 inhalation in patients with craniofacial pain caused by a putative activation of TRPV1 receptor positive trigeminal neurons has also been reported. These effects are probably mediated via an activation of TRPV1 receptor - positive neurons in the nasal mucosa with subsequent central inhibitory effects (such as conditioned pain modulation). In this study, we aimed to examine the effects of intranasal CO2 on a human model of craniofacial pain elicited by nasal application of capsaicin.
Methods: In a first experiment, 48 healthy volunteers without previous craniofacial pain received intranasal capsaicin to provoke trigeminal pain elicited by activation of TRVP1 positive nociceptive neurons. Then, CO2 or air was insufflated alternatingly into the nasal cavity at a flow rate of 1 l/min for 60 sec each. In the subsequent experiment, all participants were randomized into 2 groups of 24 each and received either continuous nasal insufflation of CO2 or placebo for 18:40 min after nociceptive stimulation with intranasal capsaicin. In both experiments, pain was rated on a numerical rating scale every 60 sec.
Results: Contrary to previous animal studies, the effects of CO2 on experimental trigeminal pain were only marginal. In the first experiment, CO2 reduced pain ratings only minimally by 5.3% compared to air if given alternatingly with significant results for the main factor GROUP (F1,47=4.438; p=0.041) and the interaction term TIME*GROUP (F2.6,121.2=3.3; p=0.029) in the repeated-measures ANOVA. However, these effects were abrogated after continuous insufflation of CO2 or placebo with no significant changes for the main factors or the interaction term.
Conclusions: Although mild modulatory effects of low-flow intranasal CO2 could be seen in this human model of TRPV-1 mediated activation of nociceptive trigeminal neurons, utility is limited as observed changes in pain ratings are clinically non-significant.
Figures




Similar articles
-
Trigeminal antihyperalgesic effect of intranasal carbon dioxide.Life Sci. 2010 Jul 3;87(1-2):36-41. doi: 10.1016/j.lfs.2010.05.013. Epub 2010 Jun 1. Life Sci. 2010. PMID: 20561904 Free PMC article.
-
Effect of the TRPV1 antagonist SB-705498 on the nasal parasympathetic reflex response in the ovalbumin sensitized guinea pig.Br J Pharmacol. 2013 Jun;169(3):580-9. doi: 10.1111/bph.12145. Br J Pharmacol. 2013. PMID: 23441756 Free PMC article.
-
TRPV1 and TRPA1 stimulation induces MUC5B secretion in the human nasal airway in vivo.Clin Physiol Funct Imaging. 2011 Nov;31(6):435-44. doi: 10.1111/j.1475-097X.2011.01039.x. Epub 2011 Jul 26. Clin Physiol Funct Imaging. 2011. PMID: 21981454 Clinical Trial.
-
Intranasal capsaicin in management of nonallergic (vasomotor) rhinitis.Prog Drug Res. 2014;68:147-70. doi: 10.1007/978-3-0348-0828-6_6. Prog Drug Res. 2014. PMID: 24941668 Review.
-
Injectable Capsaicin for the Management of Pain Due to Osteoarthritis.Molecules. 2021 Feb 3;26(4):778. doi: 10.3390/molecules26040778. Molecules. 2021. PMID: 33546181 Free PMC article. Review.
Cited by
-
Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia.Drugs. 2018 Sep;78(14):1433-1442. doi: 10.1007/s40265-018-0964-9. Drugs. 2018. PMID: 30178160 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous